Who Supplies Diltiazem? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Diltiazem exports, with 184+ registered manufacturers shipping to buyers across 71+ countries — yet a handful of companies dominate the shipments. MAIVA PHARMA PRIVATE LIMITED holds the largest share at 12.9% (export value: $2.3M). Close behind, EMCURE PHARMACEUTICALS LIMITED (12.0%, $2.2M). PIRAMAL PHARMA LIMITED (7.8%, $1.4M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Diltiazem? Top Manufacturers & Their Buyers
Flow of Diltiazem from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Diltiazem Supplier Network — Key Market Intelligence
The Diltiazem export market from India is led by MAIVA PHARMA PRIVATE LIMITED, which alone commands a 12.9% share, shipping $2.3M worth of product across 47 shipments. The second-largest exporter, EMCURE PHARMACEUTICALS LIMITED, contributes $2.2M (12.0%) to the overall market. Combined, the top two suppliers alone account for 24.9% of all Diltiazem exports, indicating a relatively concentrated supply base.
Across all 184 tracked manufacturers, the total Diltiazem export value stands at $18.0M from 1.8K shipments. The market average shipment value is $9.9K. The single largest buyer relationship in terms of trade value is EVERSANA LIFE SCIENCES SERVICES LLC, receiving $1.4M worth of product.
The combined buyer network spans 9 named purchasing companies, including EVERSANA LIFE SCIENCES SERVICES LLC, EVERSANA LIFESCIENCE SERVICES, MARCAN PHARMACEUTICALS INC, MARCAN PHARMA, PRIME LABS LTD and 4 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MAIVA PHARMA PRIVATE LIMITED
MAIVA PHARMA PRIVATE LIMITED is the first-largest Diltiazem exporter from India, with a market share of 12.9% and a total export value of $2.3M across 47 shipments. Their average shipment value of $49.3K is above the market average of $9.9K, suggesting premium or bulk contract pricing.
MAIVA PHARMA PRIVATE LIMITED serves 4 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 61.1% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES LLC — $1.4M across 29 shipments (61.1% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES LLC — $673.3K across 14 shipments (29.0% of this supplier's total exports)
• EVERSANA LIFESCIENCE SERVICES — $125.8K across 3 shipments (5.4% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES LLC — $103.9K across 2 shipments (4.5% of this supplier's total exports)
Key Insight: MAIVA PHARMA PRIVATE LIMITED's per-shipment value of $49.3K is 398% above the market average of $9.9K, consistent with large-order contracts or value-added formulations.
2EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the second-largest Diltiazem exporter from India, with a market share of 12.0% and a total export value of $2.2M across 130 shipments. Their average shipment value of $16.7K is above the market average of $9.9K, suggesting premium or bulk contract pricing.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MARCAN PHARMACEUTICALS INC — $816.4K across 49 shipments (37.7% of this supplier's total exports)
• MARCAN PHARMACEUTICALS INC — $760.7K across 46 shipments (35.1% of this supplier's total exports)
• MARCAN PHARMACEUTICALS INC — $590.5K across 35 shipments (27.2% of this supplier's total exports)
• MARCAN PHARMA — $22 across 0 shipments (0.0% of this supplier's total exports)
• PRIME LABS LTD — $4 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED's per-shipment value of $16.7K is 68% above the market average of $9.9K, consistent with large-order contracts or value-added formulations.
3PIRAMAL PHARMA LIMITED
PIRAMAL PHARMA LIMITED is the third-largest Diltiazem exporter from India, with a market share of 7.8% and a total export value of $1.4M across 37 shipments. Their average shipment value of $38.2K is above the market average of $9.9K, suggesting premium or bulk contract pricing.
PIRAMAL PHARMA LIMITED serves 3 named buyers in our database. TEVA PHARMACEUTICALS USA INC is the dominant customer, accounting for 70.1% of this supplier's tracked business. Top customers include:
• TEVA PHARMACEUTICALS USA INC — $989.7K across 26 shipments (70.1% of this supplier's total exports)
• TEVA PHARMACEUTICALS USA INC — $422.6K across 11 shipments (29.9% of this supplier's total exports)
• MATEA KOVACIC PLIVA — $8 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: PIRAMAL PHARMA LIMITED's per-shipment value of $38.2K is 286% above the market average of $9.9K, consistent with large-order contracts or value-added formulations.
4GLOBAL PHARMATECH PRIVATE LIMITED
GLOBAL PHARMATECH PRIVATE LIMITED is the fourth-largest Diltiazem exporter from India, with a market share of 6.1% and a total export value of $1.1M across 13 shipments. Their average shipment value of $84.9K is above the market average of $9.9K, suggesting premium or bulk contract pricing.
GLOBAL PHARMATECH PRIVATE LIMITED serves 2 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 78.0% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES LLC — $860.8K across 10 shipments (78.0% of this supplier's total exports)
• EVERSANA — $242.7K across 3 shipments (22.0% of this supplier's total exports)
Key Insight: GLOBAL PHARMATECH PRIVATE LIMITED's per-shipment value of $84.9K is 757% above the market average of $9.9K, consistent with large-order contracts or value-added formulations.
5MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the fifth-largest Diltiazem exporter from India, with a market share of 4.8% and a total export value of $866.5K across 29 shipments. Their average shipment value of $29.9K is above the market average of $9.9K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 3 named buyers in our database. MYLAN PHARMACEUTICALS INC, is the dominant customer, accounting for 58.7% of this supplier's tracked business. Top customers include:
• MYLAN PHARMACEUTICALS INC, — $508.9K across 17 shipments (58.7% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC, — $271.5K across 9 shipments (31.3% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC, — $86.1K across 3 shipments (9.9% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $29.9K is 202% above the market average of $9.9K, consistent with large-order contracts or value-added formulations.
6INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the fifth-largest Diltiazem exporter from India, with a market share of 3.3% and a total export value of $590.2K across 26 shipments. Their average shipment value of $22.7K is above the market average of $9.9K, suggesting premium or bulk contract pricing.
INTAS PHARMACEUTICALS LIMITED serves 2 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 58.3% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES LLC — $344.0K across 15 shipments (58.3% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES LLC — $246.1K across 11 shipments (41.7% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $22.7K is 129% above the market average of $9.9K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Diltiazem Flows
Once Diltiazem leaves the manufacturing plants of companies like MAIVA PHARMA PRIVATE LIMITED and EMCURE PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $18.0M. United States absorbs the largest share at 62.4% ($11.2M), followed by Canada (18.8%) and Sri Lanka (8.8%).
In United States — the top destination — named importers include EVERSANA LIFE SCIENCE SERVICES, TEVA PHARMACEUTICALS USA, INC, EVERSANA LIFE SCIENCES SERVICES,LLC. In Canada, key buyers are MARCAN PHARMACEUTICALS INC., MARCAN PHARMACEUTICALS INC.,, MARCAN PHARMACEUTICALS INC.
This geographic spread reflects Diltiazem's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Diltiazem Go? Top Importing Countries & Their Buyers
Trade flow of Diltiazem exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Diltiazem imports from India, with a total trade value of $11.2M across 174 shipments — representing a 62.4% share of all Diltiazem exports. The average shipment value of $64.6K is above the global average of $9.9K, indicating high-value procurement contracts or branded formulations. This market is served by 14 tracked buyers.
Named Diltiazem importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 20.3% ($2.3M) of this market's total imports.
• EVERSANA LIFE SCIENCE SERVICES — $2.3M (20.3% of United States's total)
• TEVA PHARMACEUTICALS USA, INC — $1.6M (14.5% of United States's total)
• EVERSANA LIFE SCIENCES SERVICES,LLC — $1.4M (12.7% of United States's total)
Key Insight: United States's per-shipment average of $64.6K (552% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Diltiazem imports from India.
2Canada
Canada ranks as the second-largest destination for Diltiazem imports from India, with a total trade value of $3.4M across 124 shipments — representing a 18.8% share of all Diltiazem exports. The average shipment value of $27.3K is above the global average of $9.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Diltiazem importers in Canada: MARCAN PHARMACEUTICALS INC. is the largest buyer, accounting for 47.9% ($1.6M) of this market's total imports.
• MARCAN PHARMACEUTICALS INC. — $1.6M (47.9% of Canada's total)
• MARCAN PHARMACEUTICALS INC., — $1.0M (29.7% of Canada's total)
• MARCAN PHARMACEUTICALS INC — $700.5K (20.7% of Canada's total)
Key Insight: Canada's per-shipment average of $27.3K (176% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Diltiazem imports from India.
3Sri Lanka
Sri Lanka ranks as the third-largest destination for Diltiazem imports from India, with a total trade value of $1.6M across 10 shipments — representing a 8.8% share of all Diltiazem exports. The average shipment value of $159.4K is above the global average of $9.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Diltiazem importers in Sri Lanka: PEOPLE S BANK is the largest buyer, accounting for 21.8% ($347.2K) of this market's total imports.
• PEOPLE S BANK — $347.2K (21.8% of Sri Lanka's total)
• COMMERCIAL BANK OF CEYLON PLC — $245.9K (15.4% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $159.4K (1510% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Diltiazem imports from India.
4United Arab Emirates
United Arab Emirates ranks as the fourth-largest destination for Diltiazem imports from India, with a total trade value of $555.9K across 91 shipments — representing a 3.1% share of all Diltiazem exports. The average shipment value of $6.1K is below the global average of $9.9K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Diltiazem importers in United Arab Emirates: MARINA FUTURE CARGO LLC is the largest buyer, accounting for 86.5% ($480.9K) of this market's total imports.
• MARINA FUTURE CARGO LLC — $480.9K (86.5% of United Arab Emirates's total)
Key Insight: United Arab Emirates receives frequent, smaller shipments of Diltiazem — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
United Arab Emirates is a key market for Diltiazem imports from India.
5Myanmar
Myanmar ranks as the fifth-largest destination for Diltiazem imports from India, with a total trade value of $272.3K across 0 shipments — representing a 1.5% share of all Diltiazem exports. The average shipment value of $272.3K is above the global average of $9.9K, indicating high-value procurement contracts or branded formulations.
Key Insight: Myanmar's per-shipment average of $272.3K (2650% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Myanmar is a key market for Diltiazem imports from India.
People Also Ask — Diltiazem Supplier & Trade Network
Who are the top suppliers of Diltiazem from India?+
Which companies buy Diltiazem from Indian manufacturers?+
Where does Diltiazem exported from India go?+
What is the market share of the top Diltiazem supplier from India?+
What is the average shipment value for Diltiazem exports from India?+
Is Diltiazem manufactured in India and exported globally?+
Which country imports the most Diltiazem from India?+
Who are the buyers of Diltiazem in Canada?+
How concentrated is the Diltiazem supplier market in India?+
How do I find verified buyers for Diltiazem in specific countries?+
Diltiazem Trade Network — Key Takeaways
- 1MAIVA PHARMA PRIVATE LIMITED is India's dominant Diltiazem exporter with a 12.9% market share and $2.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 184 suppliers collectively account for 46.9% of all tracked Diltiazem exports, with a combined trade value of $18.0M.
- 3United States is the largest destination market, absorbing 62.4% of India's Diltiazem exports ($11.2M). Canada (18.8%) and Sri Lanka (8.8%) follow.
- 4With 1.8K total shipments averaging $9.9K each, the Diltiazem export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include EVERSANA LIFE SCIENCES SERVICES LLC, EVERSANA LIFE SCIENCES SERVICES LLC, MARCAN PHARMACEUTICALS INC, MARCAN PHARMACEUTICALS INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 4 customers
6 suppliers → 71 countries
Network value: $18.0M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diltiazem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Diltiazem.
- 2.Flow Mapping: 184 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,820 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 71 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,820 Verified Shipments
184 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists